Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketanserin effects on Peripheral Temperature and Lactate
2017-003362-27Phase 4Active
- Sponsor
- OLVG
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ketanserin in critical illness, sponsored by OLVG. Primary endpoint: Change in DeltaTemperature. Started Oct 2017; status: active.
02
Drugs
ketanserin
03
Conditions
critical illness
Beyond the preview
Go deeper on 2017-003362-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003362-27.